Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
355.40 INR | +0.89% |
|
+7.68% | -2.72% |
06-02 | Biocon Receives Approval For Liraglutide Drug In India | RE |
05-20 | Biocon Says Biocon Biologics And Yoshindo Expand Access To Ustekinumab Biosimilar In Japan | RE |
Chart calendar Biocon Limited
60b8a76697af387.zt35T9AbfH-ERyAdv99Y_zRGaQmel3FlcHd6F9CPgMM.n7ieB6gsSBniCRRW5acUk3ktHDr02yIJLyEvUuXZtfOG65QDtHYUFuJyGA~e79a1ae887120b612556042bad47929b
Upcoming events on Biocon Limited
Past events on Biocon Limited
Past dividends on Biocon Limited
2024-07-04 | Annual 0.5 INR |
2023-07-06 | Annual 1.5 INR |
2022-06-29 | Annual 0.5 INR |
2019-07-17 | Annual 0.5 INR |
2018-07-18 | Annual 1 INR |
2017-07-19 | Annual 1 INR |
2016-03-16 | Interim Payment 5 INR |
2015-04-08 | Interim Payment 5 INR |
2014-07-09 | Annual 5 INR |
2013-07-10 | Bonus Payment 2.5 INR |
2013-07-10 | Annual 5 INR |
2012-07-04 | Annual 5 INR |
2011-07-06 | Final Payment 3 INR |
2011-05-04 | Interim Payment 1.5 INR |
2010-07-07 | Annual 3.5 INR |
2009-07-07 | Annual 3 INR |
2008-07-02 | Bonus Payment 2 INR |
2008-07-02 | Annual 3 INR |
2007-06-27 | Annual 3 INR |
2006-06-28 | Annual 2.5 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 81 840 80 217 2.02% | 111 742 109 756 1.81% | 147 557 145 005 1.76% | 152 617 149 892 1.82% | 176 032 | 206 442 |
EBITDA Million INR | Released Forecast Spread | 19 702 19 165 2.8% | 23 447 24 349 -3.7% | 32 987 30 198 9.24% | 31 663 30 002 5.54% | 38 851 | 48 591 |
EBIT Million INR | Released Forecast Spread | 11 560 11 206 3.16% | 12 316 13 432 -8.31% | 17 299 14 711 17.59% | 14 793 12 884 14.81% | 21 559 | 30 135 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 9 831 10 921 -9.98% | 8 971 9 079 -1.19% | 15 252 13 493 13.04% | 18 866 15 426 22.3% | 13 989 | 22 339 |
Net income Million INR | Released Forecast Spread | 6 484 6 868 -5.6% | 4 627 5 222 -11.39% | 10 225 9 492 7.72% | 10 133 8 396 20.69% | 7 180 | 13 017 |
EPS INR | Released Forecast Spread | 5,42 5,57 -2.66% | 3,87 4,10 -5.57% | 8,54 7,96 7.27% | 8,46 7,28 16.26% | 6,64 | 11,6 |
Announcement Date | 28/04/22 | 23/05/23 | 16/05/24 | 08/05/25 |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 23 197 22 925 1.19% | 29 411 27 778 5.88% | 37 739 36 262 4.07% | 34 226 35 094 -2.47% | 34 623 36 196 -4.35% | 39 537 36 732 7.64% | 39 171 38 945 0.58% | 34 329 38 257 -10.27% | 36 331 | 39 136 | 41 104 | 38 886 | 40 095 | 43 064 | 46 694 |
EBITDA Million INR | Released Forecast Spread | 4 707 4 805 -2.05% | 6 443 6 203 3.86% | 9 572 8 651 10.64% | 7 144 8 522 -16.17% | 7 416 8 475 -12.5% | 9 268 8 373 10.69% | 9 159 8 219 11.43% | 6 204 8 434 -26.44% | 7 262 | 8 271 | 9 210 | ||||
EBIT Million INR | Released Forecast Spread | 2 399 2 930 -18.13% | 3 432 2 496 37.48% | 5 935 4 400 34.88% | 3 564 4 684 -23.92% | 3 523 4 572 -22.95% | 5 123 4 553 12.52% | 5 089 4 102 24.07% | 2 150 4 883 -55.97% | 3 541 | 3 616 | 4 962 | 3 090 | 3 893 | 4 342 | 5 192 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 291 2 986 -23.28% | -255 3 209 -107.95% | 4 966 3 539 40.32% | 1 837 2 602 -29.4% | 2 143 2 676 -19.92% | 8 082 2 930 175.87% | 3 190 2 319 37.54% | 11 455 3 362 240.72% | 1 400 | 1 920 | 2 700 | ||||
Net income Million INR | Released Forecast Spread | 470 1 834 -74.37% | -418 2 136 -119.57% | 3 132 2 704 15.83% | 1 014 1 970 -48.53% | 1 256 1 652 -23.96% | 6 600 1 808 265.04% | 1 355 2 164 -37.39% | 6 597 1 704 287.1% | 423 | 1 287 | 1 687 | ||||
EPS INR | Released Forecast Spread | 0,39 1,48 -73.6% | -0,35 1,80 -119.44% | 2,62 1,95 34.36% | 0,85 1,58 -46.2% | 1,05 1,46 -28.08% | 5,51 1,62 240.12% | 1,13 1,15 -1.74% | 5,51 1,72 221.28% | 1,10 | 0,47 | 0,89 | 1,12 | 1,56 | ||
Announcement Date | 14/11/22 | 14/02/23 | 23/05/23 | 10/08/23 | 10/11/23 | 08/02/24 | 16/05/24 | 08/08/24 | - | - | - | - | - | - | - |
More events
Past sector events for Biocon Limited
2025-06-13 17:22 | FREEDOM HOLDING CORP.: Q4 2025 Earnings Release |
2025-06-13 08:45 | CHARLES SCHWAB: May 2025 Sales and Revenue Release - Activities Report |
2025-06-13 07:02 | UTILICO EMERGING MARKETS TRUST PLC: Q4 2025 Earnings Release |
2025-06-13 02:00 | OXFORD INSTRUMENTS PLC: Q4 2025 Earnings Release |
2025-06-13 02:00 | AVI GLOBAL TRUST PLC: Q2 2025 Earnings Release |
2025-06-13 01:00 | FRAPORT AG: May 2025 Sales and Revenue Release - Traffic Figures |
2025-06-12 | ASTROSCALE HOLDINGS INC.: Q4 2024 Earnings Release |
2025-06-12 | KURA SUSHI,INC.: Q2 2025 Earnings Release |
2025-06-12 | H.I.S. CO., LTD.: Q2 2025 Earnings Release |
2025-06-12 | J.S.B.CO.,LTD.: Q2 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOCON Stock
- Calendar Biocon Limited
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition